# Clinical Trial to Evaluate the Efficacy and Safety of SUBMO® as a Submucosal Injection Agent in Endoscopic Resection of Superficial Gastrointestinal Lesions.

> **NCT07448129** · NA · NOT_YET_RECRUITING · sponsor: **i+Med S.Coop.** · enrollment: 300 (estimated)

## Conditions studied

- Colorectal Polyps

## Interventions

- **DEVICE:** SUBMO® Submucosal Injection
- **DEVICE:** Normal Saline (0.9% Sodium Chloride) with Surface Dye Injection

## Key facts

- **NCT ID:** NCT07448129
- **Lead sponsor:** i+Med S.Coop.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-03-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07448129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07448129, "Clinical Trial to Evaluate the Efficacy and Safety of SUBMO® as a Submucosal Injection Agent in Endoscopic Resection of Superficial Gastrointestinal Lesions.". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT07448129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*